Responses
Poster Presentation
Rheumatoid arthritis - other biologic treatment
FRI0223 Long-term targeted safety event rates in ra patients following initiation of rituximab: interim analysis from sunstone registry
Compose a Response to This Article
Other responses
No responses have been published for this article.